ERBB2 and breast cancer: It has been studied that synthetic mammography from digital breast tomosynthesis radiomics signature could discriminate TN, HER2, and luminal subtypes of breast cancer, which yielded an AUC of 0.838, 0.556, and 0.645, respectively, in the validation cohort (25).